Cannabis Bioscience International Holdings (CBIH) Return on Capital Employed (2024 - 2026)

Cannabis Bioscience International Holdings has disclosed Return on Capital Employed across 3 years of filings, most recently posting 33.03% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 33.03%, down 41.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 33.03% (down 41.0% YoY), and the FY2025 annual result was 46.74%, down 1171.0% from the prior year.
• Return on Capital Employed came in at 33.03% for Q1 2026 at Cannabis Bioscience International Holdings, down from 38.98% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 100.43% in Q1 2024 to a low of 33.03% in Q1 2026.
• The 3-year median for Return on Capital Employed is 41.68% (2024), against an average of 48.7%.
• Across the five-year window, Return on Capital Employed plunged 6699 bps in 2025 and plunged 41 bps in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Return on Capital Employed stood at 41.68% in 2024, then fell by 6 bps to 38.98% in 2025, then declined by 15 bps to 33.03% in 2026.
• The last three Return on Capital Employed figures came in at 33.03% (Q1 2026), 38.98% (Q4 2025), and 40.25% (Q3 2025), per Business Quant data.